Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Voronkov

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Journal of Cosmetic Dermatology|January 13, 2016
In vitro and clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti-aging and antioxidant activitiesJosé R Fernández, Karl Rouzard, Michael Voronkov, et al.
Archives of Dermatological Research|December 19, 2016
N-Acetylglutaminoyl-S-farnesyl-L-cysteine (SIG-1191): an anti-inflammatory molecule that increases the expression of the aquaglyceroporin, aquaporin-3, in human keratinocytesJosé R Fernández, Corey Webb, Karl Rouzard, et al.
Journal of Cosmetic Dermatology|May 8, 2020
HYVIA™: A novel, topical chia seed extract that improves skin hydrationKristen L Huber, José R Fernández, Corey Webb, et al.
Journal of Cosmetic Dermatology|November 24, 2012
SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skinJosé R Fernandéz, Karl Rouzard, Michael Voronkov, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2018
Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBRun Yan, Jie Zhang, Hye-Jin Park, et al.
Experimental Dermatology|May 26, 2018
SIG1459: A novel phytyl-cysteine derived TLR2 modulator with in vitro and clinical anti-acne activityJosé R Fernández, Corey Webb, Karl Rouzard, et al.
Annals of Neurology|March 31, 2015
Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson diseaseLisa F Potts, Eun S Park, Jong-Min Woo, et al.
Journal of Cosmetic Dermatology|November 21, 2018
SIG-1273 protects skin against urban air pollution and when formulated in AgeIQ™ Night Cream anti-aging benefits clinically demonstratedJosé R Fernández, Corey Webb, Karl Rouzard, et al.
Plos One|December 19, 2017
Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloidKesava Asam, Agnieszka Staniszewski, Hong Zhang, et al.
Journal of Neuropathology and Experimental Neurology|December 28, 2017
Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseHye-Jin Park, Kang-Woo Lee, Stephanie Oh, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Journal of Cosmetic Dermatology|January 13, 2016
In vitro and clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti-aging and antioxidant activitiesJosé R Fernández, Karl Rouzard, Michael Voronkov, et al.
Archives of Dermatological Research|December 19, 2016
N-Acetylglutaminoyl-S-farnesyl-L-cysteine (SIG-1191): an anti-inflammatory molecule that increases the expression of the aquaglyceroporin, aquaporin-3, in human keratinocytesJosé R Fernández, Corey Webb, Karl Rouzard, et al.
Journal of Cosmetic Dermatology|May 8, 2020
HYVIA™: A novel, topical chia seed extract that improves skin hydrationKristen L Huber, José R Fernández, Corey Webb, et al.
Journal of Cosmetic Dermatology|November 24, 2012
SIG1273: a new cosmetic functional ingredient to reduce blemishes and Propionibacterium acnes in acne prone skinJosé R Fernandéz, Karl Rouzard, Michael Voronkov, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 5, 2018
Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLBRun Yan, Jie Zhang, Hye-Jin Park, et al.
Experimental Dermatology|May 26, 2018
SIG1459: A novel phytyl-cysteine derived TLR2 modulator with in vitro and clinical anti-acne activityJosé R Fernández, Corey Webb, Karl Rouzard, et al.
Annals of Neurology|March 31, 2015
Dual κ-agonist/μ-antagonist opioid receptor modulation reduces levodopa-induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model of Parkinson diseaseLisa F Potts, Eun S Park, Jong-Min Woo, et al.
Journal of Cosmetic Dermatology|November 21, 2018
SIG-1273 protects skin against urban air pollution and when formulated in AgeIQ™ Night Cream anti-aging benefits clinically demonstratedJosé R Fernández, Corey Webb, Karl Rouzard, et al.
Plos One|December 19, 2017
Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer's disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloidKesava Asam, Agnieszka Staniszewski, Hong Zhang, et al.
Journal of Neuropathology and Experimental Neurology|December 28, 2017
Protein Phosphatase 2A and Its Methylation Modulating Enzymes LCMT-1 and PME-1 Are Dysregulated in Tauopathies of Progressive Supranuclear Palsy and Alzheimer DiseaseHye-Jin Park, Kang-Woo Lee, Stephanie Oh, et al.
Pageof 3